Portfolio company
Ischemia Technologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and manufactures in vitro diagnostic products for cardiovascular and acute care medicine to assist clinicians in detecting cardiac ischemia.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
EP Solutions SA
This company develops non-invasive cardiac mapping technology to assist physicians in diagnosing rhythm disturbances and improving outcomes for heart failure patients.
Rapidscan
This company develops biopharmaceutical stress agents used for cardiovascular disease diagnosis in healthcare settings.
CardioInsight
This company develops non-invasive cardiac mapping systems that generate three-dimensional images of heart electrical activity for clinicians treating patients with rhythm disorders.
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
iRhythm
This company develops wearable cardiac monitoring patches and analysis software for healthcare providers to diagnose heart rhythm disorders in patients.
CAD TREATMENT OPTIMIZATION
This medical technology company develops advanced intravascular imaging systems to help cardiologists assess and treat coronary artery disease in patients.
Genetesis
This company develops non-invasive biomagnetic imaging systems to help emergency departments and cardiologists diagnose cardiovascular disease and triage chest pain.
Cardisio
This company develops non-invasive screening technology using artificial intelligence and vectorcardiography to detect heart diseases for healthcare professionals and clinical practices.
